Rexulti 4 mg 28 tablets

Medication name: Rexulti 4 mg Tablets contain the active ingredient Brexpiprazole, which belongs to the class of atypical antipsychotics.

Each pack contains 28 film-coated tablets for oral use.

Use: This medication is prescribed for the treatment of schizophrenia in adults and as an adjunct therapy for major depressive disorder (MDD) in combination with antidepressants.

It helps improve mood, reduce hallucinations, and stabilize thought and behavior patterns.

How it works: Brexpiprazole acts by modulating dopamine (D₂) and serotonin (5-HT₁A and 5-HT₂A) receptors in the brain.

This helps balance neurotransmitter activity, leading to improved emotional stability and reduced psychotic symptoms.

Dosage and administration: The usual dose is once daily, with or without food, as prescribed by a healthcare professional.

Tablets should be swallowed whole with water and not chewed or crushed.

The dosage may vary depending on the patient’s condition and response to treatment.

Side effects: Common side effects include weight gain, restlessness (akathisia), headache, drowsiness, fatigue, dizziness, and gastrointestinal discomfort.

These effects are generally mild and may lessen over time.

Precautions: Rexulti is not approved for dementia-related psychosis in elderly patients.

It should be used cautiously in individuals with heart disease, diabetes, or seizure disorders.

Avoid alcohol and sedative drugs, and do not stop the medication suddenly without consulting your doctor.

Storage: Store at room temperature (20–25 °C), in a dry place, away from light and moisture, and out of the reach of children.